Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on November 3, 2008

Hypertension. 2008
Published online before print November 3, 2008, doi: 10.1161/HYPERTENSIONAHA.108.120881
A more recent version of this article appeared on December 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
52/6/1161    most recent
HYPERTENSIONAHA.108.120881v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LaMarca, B.
Right arrow Articles by Granger, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LaMarca, B.
Right arrow Articles by Granger, J. P.
Related Collections
Right arrow Other hypertension

Submitted on August 1, 2008
Revised on August 29, 2008

Hypertension in Response to Chronic Reductions in Uterine Perfusion in Pregnant Rats. Effect of Tumor Necrosis Factor-{alpha} Blockade

Babbette LaMarca; Josh Speed; Lillian Fournier; Sara A. Babcock; Hunter Berry; Kathy Cockrell; and Joey P. Granger*

From the Department of Physiology and Biophysics, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson.

* To whom correspondence should be addressed. E-mail: jgranger{at}physiology.umsmed.edu.

Abstract—Reductions in uterine perfusion pressure (RUPP) in pregnant rats is associated with increased tumor necrosis factor-{alpha} (TNF-{alpha}). This study was designed to determine the role of endogenous TNF-{alpha} in mediating changes in arterial pressure and endothelin-1 (ET-1) in RUPP rats. To achieve this goal we examined the effect of RUPP in the presence and absence of a TNF-{alpha}–soluble receptor, etanerecept (0.4 mg/kg). Mean arterial pressure increased from 102±1 mm Hg in normal pregnant (NP) rats to 134±3 mm Hg (P<0.05) in RUPP rats. Serum TNF-{alpha} increased to 40±7.6 pg/mL in RUPP rats (n=24) versus 14.8±3.3 pg/mL (n=16; P<0.05) in NP rats. Administration of etanerecept decreased TNF-{alpha} in RUPP rats (n=20) to 17.2±3 pg/mL and mean arterial pressure to 118±2 mm Hg (P<0.05). Tissue ET-1 decreased in etanerecept-treated RUPP rats compared with control RUPP rats. The direct effect of TNF-{alpha} blockade on endothelial activation in response to placental ischemia was examined in human umbilical vein endothelial cells. ET-1 secreted from human umbilical vein endothelial cells treated with RUPP serum was 59.2+16 pg/mg and decreased when etanerecept was added to the medium with RUPP serum (7.60±0.77 pg/mg), as well as in response to serum from etanerecept-treated RUPP rats (7.30±0.55 pg/mg; P<0.001). ET-1 secreted from human umbilical vein endothelial cells was 15.6±2 pg/mg when treated with NP serum. These data support the hypothesis that endogenous TNF-{alpha} is an important stimulus for ET-1 in response to placental ischemia and is important in mediating endothelial cell activation and hypertension during pregnancy.


Key words: hypertension • pregnancy • inflammation • cytokines • endothelial activation




This article has been cited by other articles:


Home page
HypertensionHome page
S. K. Walsh, F. A. English, E. J. Johns, and L. C. Kenny
Plasma-Mediated Vascular Dysfunction in the Reduced Uterine Perfusion Pressure Model of Preeclampsia: A Microvascular Characterization
Hypertension, August 1, 2009; 54(2): 345 - 351.
[Abstract] [Full Text] [PDF]